» Articles » PMID: 29868529

Application of a New Established System for Toxic Doses in Children With 4-Hydroxycoumarin Rodenticide Intoxication

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2018 Jun 6
PMID 29868529
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The toxic dose of rodenticides in children is extremely difficult to be determined because of the uncertain exposure history. We established and validated a method to identify the toxic dose in children of 4-hydroxycoumarin (TDCH). Items were selected by Delphi method and weighted by analytic hierarchy process. Toxic doses were classified into three categories: high dose (>24 points), medium (15-24) and low (<15). Sixty-five children with 4-hydroxycoumarin rodenticide intoxication were included in the study. There were 29(44.6%), 8(12.3%), 28(43.1%) cases in high, medium, and low dose respectively. Patients in high-dose were more likely to have intentionally attempted suicide (5/29, 17.2%) or had no definite history of ingestion (17/29, 58.6%), arrived at the hospital later than 24 h (26/29, 90%), been misdiagnosed initially (25/29, 86.2%), not treated by gastric lavage (27/29, 93.1%), and developed severe hemorrhage. While most patients in low-dose were younger than 6 years (26/28, 92.9%), all have experienced accidental exposure, arrived at the hospital, and received gastric lavage within 24 h, obtained a definite diagnosis, and be asymptomatic. Of 38 patients arrived at hospital within 48 h, patients a score ≥ 15 had higher incidence of coagulopathy (6/8, 75.0%) than patients with a score < 15 (3/30, 10.0%). Of all patients, 37 in the high and medium dose with a score ≥ 15 has higher incidence (35/37, 94.6%) of prolonged administration with vitamin K (≥1 month) than other 28 patients with a score < 15 (0/28, 0%). The TDCH system could not only be used in evaluating toxic doses and predicting coagulopathy in the early stage, but also helps to guide appropriate treatment. Patients with a score ≥ 15 were in the high bleeding risk category. And patients with a scores ≥ 15 required treatment with vitamin K for more than a month.

Citing Articles

Rodenticide Poisoning.

DSilva C, Krishna B Indian J Crit Care Med. 2020; 23(Suppl 4):S272-S277.

PMID: 32021003 PMC: 6996659. DOI: 10.5005/jp-journals-10071-23318.

References
1.
King N, Tran M . Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management. Transfus Med Rev. 2015; 29(4):250-8. DOI: 10.1016/j.tmrv.2015.06.002. View

2.
Lipton R, Klass E . Human ingestion of a 'superwarfarin' rodenticide resulting in a prolonged anticoagulant effect. JAMA. 1984; 252(21):3004-5. View

3.
Caravati E, Erdman A, Scharman E, Woolf A, Chyka P, Cobaugh D . Long-acting anticoagulant rodenticide poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007; 45(1):1-22. DOI: 10.1080/15563650600795487. View

4.
Sharma P, Bentley P . Of rats and men: superwarfarin toxicity. Lancet. 2005; 365(9459):552-3. DOI: 10.1016/S0140-6736(05)17923-9. View

5.
Hellemans J, VORLAT M, Verstraete M . SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES. Br J Haematol. 1963; 9:506-12. DOI: 10.1111/j.1365-2141.1963.tb05475.x. View